Skip to content

Clinical trials

Completed Phase 3 Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Phase 3 Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20054
20062
20072
20082
20102
20111
20121
20134
20142
20151
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Novartis3
Alcon Research2
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA2
Medical University of Vienna2
Bayer1
Chengdu Kanghong Biotech Co., Ltd.1
Genentech, Inc.1
National Eye Institute (NEI)1
Shahid Beheshti University of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization27
Macular Degeneration16
Vision Disorders5
Geographic Atrophy3
Myopia, Degenerative3
Wet Macular Degeneration3
Eye Diseases2
Retinal Diseases2
Angioid Streaks1
Diabetic Retinopathy1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.